ReviewRegenerative biomaterials2026
Targeting delayed healing tissues: immune reprogramming of adaptive immune cells by biomaterials.
Review in Regenerative biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Immunoengineering External Field Responsive Biomaterials for Tissue Repair and Regeneration.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- Smart Nanomaterials and Natural Biologics for Innate-Adaptive Immune Reprogramming: A Nanobiotechnology Framework for Translational Medicine.Nanomaterials (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The adaptive immune system plays a pivotal role in coordinating tissue regeneration. Effective tissue repair and functional recovery depend on precisely regulating adaptive immune cells, especially T and B lymphocytes, and their dynamic crosstalk with innate immune cells. The immunomodulatory effects of biomaterials on adaptive cells could be realized through their influence on innate immune cells. This presents a promising therapeutic strategy, in which biomaterials can be designed to modulate immune activity toward pro-regenerative pathways and enhance healing. This review summarizes current knowledge on the molecular mechanisms that distinguish efficient acute healing from pathological chronic or delayed repair processes. Special attention is given to how key physicochemical properties of biomaterials influence the behavior of immune cells, with a specific emphasis on modulating adaptive immune responses. Understanding these biomaterial-immune cell interactions would advance the fundamental understanding of immunomodulatory biomaterials and provide a rational framework for designing next-generation biomaterials with optimized properties. This approach would help harness the body's intrinsic immune mechanisms to improve the outcomes of tissue regeneration. Future studies will refine these design principles to accelerate clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.